Date: Jan 8, 2020 11:30 AM - 12:30 PM
The Tennessee Pharmacists Consortium for Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- Identify the clinical indications and appropriate use for newly approved agents in 2019
- Describe the mechanism of action (MOA), adverse events, contraindications, and other notable risks associated with the new medications
- Discuss clinically significant counseling points for each medication
- Compare new agents to older medications and discuss their potential place in therapy
Robin Parker, PharmD
Brief Bio : Parker received her Doctor of Pharmacy degree from the University of Mississippi School of Pharmacy in 2013, where she also did her undergraduate work. She then completed a PGY-1 Community Pharmacy Residency, followed by a PGY-2 Ambulatory Care Residency, through Lipscomb University College of Pharmacy, working in conjunction with the Vanderbilt University School of Nursing at the Clinic at Mercury Courts, which works to provide care to indigent populations in Nashville. She serves in the Drug Information Center for the College and coordinates the Drug Literature Evaluation and Biostatistics and Seminar I and II courses. Currently, Parker works at Vanderbilt University Medical Center in a transitions of care clinical trial aimed at reducing polypharmacy in the elderly population.